-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Beyond HLA: Optimizing Non-HLA Variables

Program: Spotlight Sessions
Session: Making a Match: Optimal Donor HLA and Beyond
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality)
Monday, December 9, 2024, 10:30 AM-11:45 AM

Mohamad Mohty, MD, PhD

Sorbonne University, Saint-Antoine Hospital, Paris, France

Disclosures: Mohty: Adaptive: Honoraria; BMS: Consultancy, Honoraria; Takeda: Honoraria; GSK: Honoraria; Novartis: Honoraria; Stemline Menarini: Honoraria; Jazz: Consultancy, Honoraria, Research Funding, Speakers Bureau; Amgen: Honoraria; Pfizer: Consultancy, Current holder of stock options in a privately-held company, Honoraria, Research Funding, Speakers Bureau; Janssen: Consultancy, Honoraria, Research Funding, Speakers Bureau; Sanofi: Consultancy, Honoraria, Research Funding, Speakers Bureau; MaaT Pharma: Current equity holder in publicly-traded company.

See more of: Making a Match: Optimal Donor HLA and Beyond
See more of: Spotlight Sessions
<< Previous Presentation | Next Presentation